AroCell AB (publ)
SSE:AROC.ST
0.405 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 43.039 | 36.986 | 11.996 | 0.084 | 0.443 | 0.782 | 0.502 | 0.055 | 0.46 | 0 | 0 | 0 | 0 | 0.027 |
| Cost of Revenue
| 45.141 | 39.091 | 17.041 | 0.021 | 0.372 | 1.252 | 0.276 | 0 | 0 | 0 | 0 | 0.015 | 0 | 0 |
| Gross Profit
| -2.102 | -2.105 | -5.045 | 0.063 | 0.071 | -0.47 | 0.226 | 0.055 | 0.46 | 0 | 0 | -0.015 | 0 | 0.027 |
| Gross Profit Ratio
| -0.049 | -0.057 | -0.421 | 0.75 | 0.159 | -0.601 | 0.45 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Reseach & Development Expenses
| 25.243 | 24.425 | 19.828 | 12.596 | 9.513 | 9.855 | 7.705 | 2.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 15.808 | 19.464 | 10.605 | 5.254 | 4.387 | 4.189 | 3.633 | 4.921 | 5.273 | 4.828 | 3.615 | 3.003 | 0 | 0 |
| Selling & Marketing Expenses
| 17.261 | 16.359 | 15.394 | 6.213 | 6.93 | 6.243 | 6.154 | 5.02 | 0 | 0 | 0 | 0 | 2.905 | 1.484 |
| SG&A
| 33.069 | 35.823 | 25.999 | 11.467 | 11.317 | 10.432 | 9.787 | 4.921 | 5.273 | 4.828 | 3.615 | 3.003 | 2.905 | 1.484 |
| Other Expenses
| -0.417 | -2.231 | -0.056 | 0.052 | -0.024 | 0 | 0 | 4.307 | 2.211 | 1.582 | 0.104 | 0.127 | 0.6 | 0.634 |
| Operating Expenses
| 58.312 | 58.017 | 45.771 | 24.115 | 20.806 | 20.287 | 17.492 | 9.229 | 7.485 | 6.41 | 3.719 | 3.13 | 3.504 | 2.118 |
| Operating Income
| -60.414 | -59.304 | -50.573 | -24.052 | -20.736 | -20.756 | -17.266 | -9.229 | -7.485 | -6.41 | -3.719 | -3.145 | -3.504 | -2.091 |
| Operating Income Ratio
| -1.404 | -1.603 | -4.216 | -286.333 | -46.839 | -26.548 | -34.393 | -169.007 | -16.263 | 0 | 0 | 0 | 0 | -77.868 |
| Total Other Income Expenses Net
| 1.117 | 0.005 | 0.299 | -0.052 | -0 | -0.001 | -0.004 | -0.006 | 0.006 | 0.041 | -0.014 | -0.012 | -0.08 | -0.061 |
| Income Before Tax
| -59.297 | -59.299 | -50.573 | -24.052 | -20.736 | -20.757 | -17.271 | -9.235 | -7.479 | -6.369 | -3.733 | -3.157 | -3.584 | -2.152 |
| Income Before Tax Ratio
| -1.378 | -1.603 | -4.216 | -286.333 | -46.84 | -26.549 | -34.402 | -169.12 | -16.251 | 0 | 0 | 0 | 0 | -80.146 |
| Income Tax Expense
| 1.13 | -0.326 | -0.547 | -4.593 | -4.534 | -4.218 | -2.268 | 0 | 0.02 | 0.078 | 0.034 | 0.06 | 0 | 0 |
| Net Income
| -59.297 | -58.973 | -50.026 | -19.459 | -16.202 | -20.757 | -17.271 | -9.235 | -7.479 | -6.369 | -3.733 | -3.157 | -3.584 | -2.152 |
| Net Income Ratio
| -1.378 | -1.594 | -4.17 | -231.655 | -36.598 | -26.549 | -34.402 | -169.12 | -16.251 | 0 | 0 | 0 | 0 | -80.146 |
| EPS
| -0.26 | -0.27 | -0.52 | -0.26 | -0.4 | -0.51 | -0.58 | -0.31 | -0.25 | -0.26 | -0.19 | -0.22 | -0.43 | -0.43 |
| EPS Diluted
| -0.26 | -0.27 | -0.52 | -0.26 | -0.4 | -0.51 | -0.58 | -0.31 | -0.25 | -0.26 | -0.19 | -0.22 | -0.43 | -0.43 |
| EBITDA
| -13.747 | -12.112 | -45.78 | -24.052 | -20.736 | -20.756 | -17.269 | -9.221 | -7.458 | -6.298 | -3.653 | -3.057 | -3.467 | -2.023 |
| EBITDA Ratio
| -0.319 | -0.327 | -3.816 | -286.333 | -46.839 | -26.548 | -34.399 | -168.862 | -16.204 | 0 | 0 | 0 | 0 | -75.346 |